APA (7th ed.) Citation

DH, K., T, P., J, H., DY, S., I, K., SS, Y., . . . Y, K. (2025). Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: A phase II study. Annals of hematology, 104(7), 3843. https://doi.org/10.1007/s00277-025-06405-y

Chicago Style (17th ed.) Citation

DH, Kim, Park T, Hong J, Shin DY, Kim I, Yoon SS, Byun JM, and Koh Y. "Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide Conditioning in Patients with Central Nervous System Lymphoma: A Phase II Study." Annals of Hematology 104, no. 7 (2025): 3843. https://doi.org/10.1007/s00277-025-06405-y.

MLA (9th ed.) Citation

DH, Kim, et al. "Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide Conditioning in Patients with Central Nervous System Lymphoma: A Phase II Study." Annals of Hematology, vol. 104, no. 7, 2025, p. 3843, https://doi.org/10.1007/s00277-025-06405-y.